
Chanh Duy Nguyen
Supervisory Patent Examiner (ID: 5233, Phone: (571)272-7772 , Office: P/2691 )
| Most Active Art Unit | 2609 |
| Art Unit(s) | 2623, 2775, 2609, 2691, 2629, 2787, 2774, 2675, 2618 |
| Total Applications | 776 |
| Issued Applications | 498 |
| Pending Applications | 50 |
| Abandoned Applications | 229 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6870614
[patent_doc_number] => 20030083304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment'
[patent_app_type] => new
[patent_app_number] => 10/251049
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11939
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251049 | CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment | Sep 19, 2002 | Abandoned |
| 10/129381 | Recombinant fusion molecules | Sep 15, 2002 | Abandoned |
Array
(
[id] => 499833
[patent_doc_number] => 07205142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/243243
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 11
[patent_no_of_words] => 11484
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243243 | Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof | Sep 12, 2002 | Issued |
Array
(
[id] => 6843061
[patent_doc_number] => 20030148408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => new
[patent_app_number] => 10/241220
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 73296
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10241220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/241220 | Compositions and methods for the diagnosis and treatment of tumor | Sep 10, 2002 | Abandoned |
Array
(
[id] => 6739749
[patent_doc_number] => 20030157118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Tumour-specific animal proteins'
[patent_app_type] => new
[patent_app_number] => 10/226872
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26035
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157118.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226872
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226872 | Tumour-specific animal proteins | Aug 22, 2002 | Abandoned |
Array
(
[id] => 7467814
[patent_doc_number] => 20040053866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Tumor suppressor genes and their uses'
[patent_app_type] => new
[patent_app_number] => 10/226997
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13420
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226997 | Tumor suppressor genes and their uses | Aug 20, 2002 | Abandoned |
Array
(
[id] => 6668779
[patent_doc_number] => 20030113762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Gleason grade 4/5 prostate cancer genes'
[patent_app_type] => new
[patent_app_number] => 10/222206
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11714
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10222206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/222206 | Gleason grade 4/5 prostate cancer genes | Aug 15, 2002 | Abandoned |
Array
(
[id] => 376816
[patent_doc_number] => 07311914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'MAGE-A4 antigenic peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/218095
[patent_app_country] => US
[patent_app_date] => 2002-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20544
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/311/07311914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10218095
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/218095 | MAGE-A4 antigenic peptides and uses thereof | Aug 12, 2002 | Issued |
Array
(
[id] => 6761209
[patent_doc_number] => 20030124571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Novel human septin and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/208304
[patent_app_country] => US
[patent_app_date] => 2002-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22990
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124571.pdf
[firstpage_image] =>[orig_patent_app_number] => 10208304
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/208304 | Novel human septin and uses therefor | Jul 28, 2002 | Abandoned |
Array
(
[id] => 6696769
[patent_doc_number] => 20030108963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/205823
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42298
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205823 | Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer | Jul 24, 2002 | Abandoned |
Array
(
[id] => 6711005
[patent_doc_number] => 20030170754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Nuclear matrix proteins, polynucleotide sequences encoding them, and their uses'
[patent_app_type] => new
[patent_app_number] => 10/197857
[patent_app_country] => US
[patent_app_date] => 2002-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8655
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10197857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/197857 | Nuclear matrix proteins, polynucleotide sequences encoding them, and their uses | Jul 18, 2002 | Abandoned |
Array
(
[id] => 6861071
[patent_doc_number] => 20030092079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions'
[patent_app_type] => new
[patent_app_number] => 10/193709
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21614
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092079.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193709 | Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions | Jul 11, 2002 | Abandoned |
Array
(
[id] => 6861075
[patent_doc_number] => 20030092083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Cage antigen'
[patent_app_type] => new
[patent_app_number] => 10/195117
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19186
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092083.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195117 | Cage antigen | Jul 10, 2002 | Abandoned |
Array
(
[id] => 906780
[patent_doc_number] => 07332287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Methods and compositions for diagnosing breast cancer'
[patent_app_type] => utility
[patent_app_number] => 10/192915
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 14127
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192915 | Methods and compositions for diagnosing breast cancer | Jul 8, 2002 | Issued |
| 10/009861 | Markers for prostate cancer | Jul 2, 2002 | Abandoned |
Array
(
[id] => 6813591
[patent_doc_number] => 20030073141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Monoclonal antibodies against a complex of human ACT and a serine protease'
[patent_app_type] => new
[patent_app_number] => 10/188607
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9103
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073141.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188607 | Monoclonal antibodies against a complex of human ACT and a serine protease | Jul 1, 2002 | Abandoned |
Array
(
[id] => 498547
[patent_doc_number] => 07204982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Compositions and methods for treatment and detection of multiple cancers'
[patent_app_type] => utility
[patent_app_number] => 10/188840
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 22934
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/204/07204982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188840
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188840 | Compositions and methods for treatment and detection of multiple cancers | Jul 1, 2002 | Issued |
Array
(
[id] => 7166093
[patent_doc_number] => 20040076955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer'
[patent_app_type] => new
[patent_app_number] => 10/188832
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 176820
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20040076955.pdf
[firstpage_image] =>[orig_patent_app_number] => 10188832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/188832 | Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer | Jul 1, 2002 | Abandoned |
Array
(
[id] => 6817678
[patent_doc_number] => 20030068636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/176847
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38968
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176847 | Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | Jun 20, 2002 | Abandoned |
Array
(
[id] => 6861649
[patent_doc_number] => 20030092657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Modulation of PAX-2 for controlled apoptosis or survival of cells'
[patent_app_type] => new
[patent_app_number] => 10/175138
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8442
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175138 | Modulation of PAX-2 for controlled apoptosis or survival of cells | Jun 18, 2002 | Abandoned |